{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T21:00:19Z","timestamp":1761166819045,"version":"build-2065373602"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pulmonary Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.pupt.2023.102231","type":"journal-article","created":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T11:59:19Z","timestamp":1688471959000},"page":"102231","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Assessing the relationship between cardiovascular and small airway disease and acute events in COPD: The ARCADIA study protocol"],"prefix":"10.1016","volume":"82","author":[{"given":"Paola","family":"Rogliani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dejan","family":"Radovanovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josuel","family":"Ora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadia","family":"Starc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Verri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Pistocchini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigino","family":"Calzetta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"author":"Cardiovascular diseases","key":"10.1016\/j.pupt.2023.102231_bib2"},{"key":"10.1016\/j.pupt.2023.102231_bib3","doi-asserted-by":"crossref","DOI":"10.1177\/1753465817750524","article-title":"Defining the relationship between COPD and CVD: what are theimplications for clinical practice?","volume":"12","author":"Morgan","year":"2018","journal-title":"Ther. Adv. Respir. Dis."},{"key":"10.1016\/j.pupt.2023.102231_bib4","doi-asserted-by":"crossref","first-page":"E398","DOI":"10.3399\/bjgp19X702725","article-title":"Comorbidity in patients with cardiovascular disease in primary care: a cohort study with routine healthcare data","volume":"69","author":"Buddeke","year":"2019","journal-title":"Br. J. Gen. Pract."},{"key":"10.1016\/j.pupt.2023.102231_bib5","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0057-2018","article-title":"Cardiovascular disease and COPD: dangerous liaisons?","volume":"27","author":"Rabe","year":"2018","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.pupt.2023.102231_bib6","article-title":"Medium-dose ICS-containing FDCs reduce all-cause mortality in COPD patients: an in-depth analysis of dual and triple therapies","author":"Calzetta","year":"2021","journal-title":"Expet Rev. Respir. Med."},{"key":"10.1016\/j.pupt.2023.102231_bib7","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S2213-2600(22)00494-5","article-title":"GOLD COPD report: 2023 update","volume":"11","author":"Venkatesan","year":"2023","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.pupt.2023.102231_bib8","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0140-6736(22)01273-9","article-title":"Towards the elimination of chronic obstructive pulmonary disease: a Lancet Commission","volume":"400","author":"Stolz","year":"2022","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.pupt.2023.102231_bib9","first-page":"381","article-title":"Hyperinflation and its management in COPD","volume":"1","author":"Puente-Maestu","year":"2006","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"key":"10.1016\/j.pupt.2023.102231_bib10","first-page":"995","article-title":"Novel aspects of pathogenesis and regeneration mechanisms in COPD","volume":"10","author":"Bagdonas","year":"2015","journal-title":"Int. J. COPD"},{"key":"10.1016\/j.pupt.2023.102231_bib11","doi-asserted-by":"crossref","DOI":"10.1186\/s12931-019-1017-y","article-title":"The pathology of small airways disease in COPD: historical aspects and future directions","volume":"20","author":"Higham","year":"2019","journal-title":"Respir. Res."},{"key":"10.1016\/j.pupt.2023.102231_bib12","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1152\/physrev.00025.2015","article-title":"The contribution of small airway obstruction to the pathogenesis of chronic obstructive pulmonary disease","volume":"97","author":"Hogg","year":"2017","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.pupt.2023.102231_bib13","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/MCP.0000000000000637","article-title":"Small airway disease in chronic obstructive pulmonary disease: insights and implications for the clinician","volume":"26","author":"Singh","year":"2020","journal-title":"Curr. Opin. Pulm. Med."},{"year":"2016","series-title":"Association between Functional Small Airways Disease and FEV 1 Decline in COPD","author":"Bhatt","key":"10.1016\/j.pupt.2023.102231_bib14"},{"key":"10.1016\/j.pupt.2023.102231_bib15","article-title":"Small airways in asthma: from bench-to-bedside","author":"Calzetta","year":"2021","journal-title":"Minerva Med."},{"key":"10.1016\/j.pupt.2023.102231_bib16","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.4187\/respcare.07237","article-title":"The relevance of targeting treatment to small airways in asthma and copd","volume":"65","author":"Santus","year":"2020","journal-title":"Respir. Care"},{"key":"10.1016\/j.pupt.2023.102231_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2020.105952","article-title":"Current place of impulse oscillometry in the assessment of pulmonary diseases","volume":"170","author":"Bednarek","year":"2020","journal-title":"Respir. Med."},{"key":"10.1016\/j.pupt.2023.102231_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.resp.2016.09.006","article-title":"Airway occlusion assessed by single breath N2 test and lung P-V curve in healthy subjects and COPD patients","volume":"234","author":"Pecchiari","year":"2016","journal-title":"Respir. Physiol. Neurobiol."},{"key":"10.1016\/j.pupt.2023.102231_bib19","first-page":"1","article-title":"CT-definable subtypes of COPD disease: a statement of the fleishner society","volume":"000","author":"Society","year":"2015","journal-title":"Radiology"},{"key":"10.1016\/j.pupt.2023.102231_bib20","unstructured":"T. Jennermann, S.M. Humphries, J.H.M. Austin, P.A. Grenier, P. Russell, T.H. Beaty, D. Curran-everett, J.E. Hokanson, C. Investigators, CT-Based Visual Classification of Emphysema : Association with Mortality in the COPDGene Study, ((n.d.))."},{"key":"10.1016\/j.pupt.2023.102231_bib21","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/17476348.2021.1840982","article-title":"Advances in understanding of mechanisms related to increased cardiovascular risk in COPD","volume":"15","author":"Rogliani","year":"2021","journal-title":"Expet Rev. Respir. Med."},{"key":"10.1016\/j.pupt.2023.102231_bib22","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0140-6736(11)60968-9","article-title":"Chronic obstructive pulmonary disease","volume":"379","author":"Decramer","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.pupt.2023.102231_bib23","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1183\/09031936.00133805","article-title":"Mortality in COPD: role of comorbidities","volume":"28","author":"Sin","year":"2006","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.pupt.2023.102231_bib24","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.amepre.2014.03.014","article-title":"Burden of cardiovascular disease in chronic obstructive pulmonary disease","volume":"47","author":"Agarwal","year":"2014","journal-title":"Am. J. Prev. Med."},{"key":"10.1016\/j.pupt.2023.102231_bib25","first-page":"1019","article-title":"Chronic obstructive pulmonary disease and coronary disease: COPDCoRi, a simple and effective algorithm for predicting the risk of coronary artery disease in COPD patients, Respir","volume":"109","author":"Cazzola","year":"2015","journal-title":"M\u00e9d."},{"key":"10.1016\/j.pupt.2023.102231_bib26","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1177\/1060028017712531","article-title":"Does cardiovascular comorbidity influence the prescribing of bronchodilators in chronic obstructive pulmonary disease?","volume":"51","author":"Adesanoye","year":"2017","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.pupt.2023.102231_bib27","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.coph.2012.04.001","article-title":"Treatment of COPD: moving beyond the lungs","volume":"12","author":"Matera","year":"2012","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.pupt.2023.102231_bib28","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1016\/j.jacc.2018.11.068","article-title":"Cardiovascular disease in chronic respiratory disorders and beyond","volume":"73","author":"Rogliani","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.pupt.2023.102231_bib29","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1056\/NEJMoa0808836","article-title":"Percent emphysema, airflow obstruction, and impaired left ventricular filling","volume":"362","author":"Barr","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pupt.2023.102231_bib30","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.chest.2022.01.031","article-title":"Severe pulmonary hypertension in COPD: impact on survival and diagnostic approach","volume":"162","author":"Kovacs","year":"2022","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2023.102231_bib31","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1183\/09031936.00124811","article-title":"Diagnosis of myocardial infarction following hospitalisation for exacerbation of COPD","volume":"39","author":"McAllister","year":"2012","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.pupt.2023.102231_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0137904","article-title":"Inhaled long-acting \u03b22-agonists do not increase fatal cardiovascular adverse events in COPD: a meta-analysis","volume":"10","author":"Xia","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.pupt.2023.102231_bib33","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.pupt.2013.03.020","article-title":"The effect of indacaterol during an acute exacerbation of COPD","volume":"26","author":"Segreti","year":"2013","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.pupt.2023.102231_bib34","first-page":"1917","article-title":"Effect of indacaterol on lung deflation improves cardiac performance in hyperinflated COPD patients: an interventional, randomized, double-blind clinical trial","volume":"10","author":"Santus","year":"2010","journal-title":"Int. J. COPD."},{"key":"10.1016\/j.pupt.2023.102231_bib35","doi-asserted-by":"crossref","DOI":"10.1136\/thx.2010.136077","article-title":"Cardiovascular events in patients with COPD: TORCH study results","volume":"65","author":"Calverley","year":"2010","journal-title":"Thorax"},{"key":"10.1016\/j.pupt.2023.102231_bib36","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/S2213-2600(18)30054-7","article-title":"Effect of lung deflation with indacaterol plus glycopyrronium on ventricular filling in patients with hyperinflation and COPD (CLAIM): a double-blind, randomised, crossover, placebo-controlled, single-centre trial","volume":"6","author":"Hohlfeld","year":"2018","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.pupt.2023.102231_bib37","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1378\/chest.09-2810","article-title":"Decreasing cardiac chamber sizes and associated heart dysfunction in COPD: role of hyperinflation","volume":"138","author":"Watz","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2023.102231_bib38","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/1465-9921-12-150","article-title":"Dynamic hyperinflation is associated with a poor cardiovascular response to exercise in COPD patients","volume":"12","author":"Tzani","year":"2011","journal-title":"Respir. Res."},{"key":"10.1016\/j.pupt.2023.102231_bib39","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.ijsu.2014.07.013","article-title":"The strengthening the reporting of observational studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"12","author":"von Elm","year":"2014","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.pupt.2023.102231_bib40","unstructured":"2023 GOLD Reports - Global Initiative for Chronic Obstructive Lung Disease - GOLD, (n.d.). https:\/\/goldcopd.org\/2023-gold-report-2\/# (accessed March 14, 2022)."},{"key":"10.1016\/j.pupt.2023.102231_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2288-14-41","article-title":"The statistical interpretation of pilot trials: should significance thresholds be reconsidered?","volume":"14","author":"Lee","year":"2014","journal-title":"BMC Med. Res. Methodol."},{"key":"10.1016\/j.pupt.2023.102231_bib44","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1177\/1740774520914306","article-title":"Bayesian methods for pilot studies","volume":"17","author":"Willan","year":"2020","journal-title":"Clin. Trials"},{"key":"10.1016\/j.pupt.2023.102231_bib45","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.0421","article-title":"Use of bayesian statistics to reanalyze data from the pragmatic randomized optimal platelet and plasma ratios trial","volume":"6","author":"Lammers","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.pupt.2023.102231_bib46","article-title":"Health status after invasive or conservative care in coronary and advanced kidney disease","volume":"382","author":"Spertus","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pupt.2023.102231_bib47","article-title":"Treatment of severe COVID-19 patients with either low- or high-volume of convalescent plasma versus standard of care: a multicenter Bayesian randomized open-label clinical trial (COOP-COVID-19-MCTI)","volume":"10","author":"Song","year":"2022","journal-title":"Lancet Reg. Heal. - Am."},{"key":"10.1016\/j.pupt.2023.102231_bib48","article-title":"1305-0013 trial investigators, trial of a preferential phosphodiesterase 4B inhibitor for idiopathic pulmonary fibrosis","author":"Richeldi","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pupt.2023.102231_bib49","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2209760","article-title":"Early treatment with pegylated interferon lambda for covid-19","volume":"388","author":"Reis","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pupt.2023.102231_bib50","doi-asserted-by":"crossref","DOI":"10.1177\/2167702618815466","article-title":"Sample size requirements for multivariate models to predict between-patient differences in best treatments of major depressive disorder","volume":"7","author":"Luedtke","year":"2019","journal-title":"Clin. Psychol. Sci."},{"key":"10.1016\/j.pupt.2023.102231_bib52","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-007536","article-title":"Impact of cardiovascular comorbidities on COPD assessment test (CAT) and its responsiveness to pulmonary rehabilitation in patients with moderate to very severe COPD: protocol of the Chance study","volume":"5","author":"Smid","year":"2015","journal-title":"BMJ Open"},{"issue":"29","key":"10.1016\/j.pupt.2023.102231_bib53","first-page":"335","article-title":"Bayesian propensity score analysis for clustered observational data","volume":"292","author":"Zhou","year":"2019","journal-title":"Stat. Methods Appl."},{"key":"10.1016\/j.pupt.2023.102231_bib54","doi-asserted-by":"crossref","DOI":"10.1002\/sim.8941","article-title":"Bayesian design and analysis of external pilot trials for complex interventions","volume":"40","author":"Wilson","year":"2021","journal-title":"Stat. Med."},{"key":"10.1016\/j.pupt.2023.102231_bib55","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1183\/09031936.05.00035005","article-title":"Standardisation of the measurement of lung volumes","volume":"26","author":"Wanger","year":"2005","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.pupt.2023.102231_bib56","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1183\/09031936.05.00034905","article-title":"Standardisation of the single-breath determination of carbon monoxide uptake in the lung","volume":"26","author":"MacIntyre","year":"2005","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.pupt.2023.102231_bib57","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1164\/rccm.201112-2160CI","article-title":"Examination of the carbon monoxide diffusing capacity (DL(CO)) in relation to its KCO and VA components","volume":"186","author":"Hughes","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.pupt.2023.102231_bib58","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1159\/000513954","article-title":"Ventilation heterogeneity in asthma and COPD: the value of the poorly communicating fraction as the ratio of total lung capacity to alveolar volume","volume":"100","author":"Pisi","year":"2021","journal-title":"Respiration"},{"key":"10.1016\/j.pupt.2023.102231_bib59","doi-asserted-by":"crossref","DOI":"10.1159\/000448847","article-title":"Improvements in lung diffusion capacity following pulmonary rehabilitation in COPD with and without ventilation inhomogeneity","volume":"92","author":"Santus","year":"2016","journal-title":"Respiration"},{"key":"10.1016\/j.pupt.2023.102231_bib60","doi-asserted-by":"crossref","DOI":"10.3109\/15412555.2014.948997","article-title":"Ventilation distribution heterogeneity at rest as a marker of exercise impairment in mild-to-advanced COPD","volume":"12","author":"Neder","year":"2015","journal-title":"COPD"},{"key":"10.1016\/j.pupt.2023.102231_bib61","doi-asserted-by":"crossref","DOI":"10.1183\/09031936.00080312","article-title":"Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations","volume":"40","author":"Quanjer","year":"2012","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.pupt.2023.102231_bib62","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00010-2017","article-title":"Official ERS technical standards: global Lung Function Initiative reference values for the carbon monoxide transfer factor for Caucasians","volume":"50","author":"Stanojevic","year":"2017","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.pupt.2023.102231_bib63","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00289-2020","article-title":"Official ERS technical standard: global lung function initiative reference values for static lung volumes in individuals of european ancestry","volume":"57","author":"Hall","year":"2021","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.pupt.2023.102231_bib64","article-title":"ERS\/ATS technical standard on interpretive strategies for routine lung function tests","volume":"60","author":"Stanojevic","year":"2022","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.pupt.2023.102231_bib65","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00239-2023","article-title":"Global initiative for chronic obstructive lung disease 2023 report: GOLD executive summary","author":"Agust\u00ed","year":"2023","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.pupt.2023.102231_bib66","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1183\/09031936.05.00035205","article-title":"Interpretative strategies for lung function tests","volume":"26","author":"Pellegrino","year":"2005","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.pupt.2023.102231_bib67","doi-asserted-by":"crossref","DOI":"10.1152\/japplphysiol.00493.2017","article-title":"Acute effects of long-acting bronchodilators on small airways detected in COPD patients by single-breath N2 test and lung P-V curve","volume":"123","author":"Pecchiari","year":"2017","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.pupt.2023.102231_bib68","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00753-2019","article-title":"Technical standards for respiratory oscillometry","volume":"55","author":"King","year":"2020","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.pupt.2023.102231_bib69","doi-asserted-by":"crossref","DOI":"10.1183\/09031936.00126212","article-title":"Respiratory impedance in healthy subjects: baseline values and bronchodilator response","volume":"42","author":"Oostveen","year":"2013","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.pupt.2023.102231_bib70","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.201511-2219OC","article-title":"Association between functional small airway disease and FEV1 decline in chronic obstructive pulmonary disease","volume":"194","author":"Bhatt","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.pupt.2023.102231_bib71","doi-asserted-by":"crossref","DOI":"10.1183\/09031936.01.00206101","article-title":"Small airways diseases: detection and insights with computed tomography","volume":"17","author":"Hansell","year":"2001","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.pupt.2023.102231_bib72","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1136\/thx.54.7.581","article-title":"Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease","volume":"54","author":"Bestall","year":"1999","journal-title":"Thorax"},{"key":"10.1016\/j.pupt.2023.102231_bib73","doi-asserted-by":"crossref","DOI":"10.1183\/09031936.00102509","article-title":"Development and first validation of the COPD assessment test","volume":"34","author":"Jones","year":"2009","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.pupt.2023.102231_bib74","doi-asserted-by":"crossref","DOI":"10.4274\/MMJ.galenos.2022.06787","article-title":"How to utilize CAT and mMRC scores to assess symptom status of patients with COPD in clinical practice?","volume":"37","author":"Ertan Yazar","year":"2022","journal-title":"Medeni. Med. J."},{"key":"10.1016\/j.pupt.2023.102231_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.jfma.2018.06.018","article-title":"Comparison between COPD Assessment Test (CAT) and modified Medical Research Council (mMRC) dyspnea scores for evaluation of clinical symptoms, comorbidities and medical resources utilization in COPD patients","volume":"118","author":"Cheng","year":"2019","journal-title":"J. Formos. Med. Assoc."},{"key":"10.1016\/j.pupt.2023.102231_bib76","doi-asserted-by":"crossref","DOI":"10.3389\/fresc.2021.729190","article-title":"Are in person and telephone interviews equivalent modes of administrating the CAT, the FACIT-FS and the SGRQ in people with COPD?","volume":"2","author":"Rocha","year":"2021","journal-title":"Front. Rehabil. Sci."}],"container-title":["Pulmonary Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553923000433?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553923000433?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T21:31:35Z","timestamp":1761082295000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094553923000433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":72,"alternative-id":["S1094553923000433"],"URL":"https:\/\/doi.org\/10.1016\/j.pupt.2023.102231","relation":{},"ISSN":["1094-5539"],"issn-type":[{"type":"print","value":"1094-5539"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing the relationship between cardiovascular and small airway disease and acute events in COPD: The ARCADIA study protocol","name":"articletitle","label":"Article Title"},{"value":"Pulmonary Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pupt.2023.102231","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102231"}}